Other
Preterm Labor
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Preterm Labor is an early-stage landscape with 0 programs across 1 company. The most active players are Ferring.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
41
clinical trials
Completed21 · 51%
Unknown status10 · 24%
Withdrawn5 · 12%
Terminated3 · 7%
Recruiting1 · 2%
Not yet recruiting1 · 2%
Clinical Trials
Trial Activity
41 trials
Vaginal Progesterone Supplementation in the Management of Preterm Labor
Completed·—·N/A·NCT03202836·90 enrolled
Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor
Completed·—·Phase 4·NCT03040752·200 enrolled
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
Completed·—·Phase 3·NCT02989519·231 enrolled
Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation
Completed·—·Phase 2·NCT01577121·16 enrolled
Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix
Completed·—·Phase 4·NCT02338830·182 enrolled
Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor
Completed·—·N/A·NCT02262481·48 enrolled
Nifedipine Compared to Atosiban for Treating Preterm Labor
Completed·—·Phase 4·NCT00599898·145 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)